Prairie Vascular Research Inc.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Heart failure1 trial

Phase

• Phase 31 trial

Status

• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Boehringer Ingelheim1 trial
• The University of Queensland1 trial

Running trials

• Recruiting

  Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

  NCT03573089· The University of Queensland· Source

  Contact: Bhanu Prasad, Dr

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting

Closed trials

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Boehringer Ingelheim· Source